کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
1399071 1501151 2013 10 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Evaluation of adenine as scaffold for the development of novel P2X3 receptor antagonists
موضوعات مرتبط
مهندسی و علوم پایه شیمی شیمی آلی
پیش نمایش صفحه اول مقاله
Evaluation of adenine as scaffold for the development of novel P2X3 receptor antagonists
چکیده انگلیسی


• Adenine moiety tested as scaffold for the development of P2X3 receptor antagonists.
• Test at rat/human P2X3 in HEK cells and at mouse trigeminal ganglion sensory neurons.
• Rapid and reversible inhibition of membrane currents induced via P2X3 activation.
• P2X3 antagonist activity with IC50 in the low micromolar range.

Ligands that selectively block P2X3 receptors localized on nociceptive sensory fibres may be useful for the treatment of chronic pain conditions including neuropathic pain, migraine, and inflammatory pain. With the aim at exploring the suitability of adenine moiety as a scaffold for the development of antagonists of this receptor, a series of 9-benzyl-2-aminoadenine derivatives were designed and synthesized. These new compounds were functionally evaluated at rat or human P2X3 receptors expressed in human embryonic kidney (HEK) cells and on native P2X3 receptors from mouse trigeminal ganglion sensory neurons using patch clamp recording under voltage clamp configuration. The new molecules behaved as P2X3 antagonists, as they rapidly and reversibly inhibited (IC50 in the low micromolar range) the membrane currents induced via P2X3 receptor activation by the full agonist α,β-methyleneATP. Introduction of a small lipophilic methyl substituent at the 6-amino group enhanced the activity, in comparison to the corresponding unsubstituted derivative, resulting in the 9-(5-iodo-2-isopropyl-4-methoxybenzyl)-N6-methyl-9H-purine-2,6-diamine (24), which appears to be a good antagonist on recombinant and native P2X3 receptors with IC50 = 1.74 ± 0.21 μM.

Figure optionsDownload as PowerPoint slide

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: European Journal of Medicinal Chemistry - Volume 65, July 2013, Pages 41–50
نویسندگان
, , , , , , , , , , , ,